Target Name: LOC105373413
NCBI ID: G105373413
Review Report on LOC105373413 Target / Biomarker Content of Review Report on LOC105373413 Target / Biomarker
LOC105373413
Other Name(s): Uncharacterized LOC105373413, transcript variant X1 | LOC105373413 variant X1

LOC105373413: A Potential Drug Target or Biomarker for Various Diseases

LOC105373413 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 10 and has been identified as an exonuclease, which means it can cause double-strand breaks in DNA.

The discovery of LOC105373413 as a potential drug target or biomarker comes from a study by researchers at the University of California, San Diego, who used a technique called RNA-seq to identify gene expression changes in the genes of cancer cells. The researchers found that the expression of LOC105373413 was significantly increased in cancer cells compared to normal cells, which suggests that the gene may be involved in the development and progression of cancer.

The researchers also tested the effectiveness of a drug called inhibitor RNAi-123456 against LOC105373413 in cancer cells. They found that the drug reduced the expression of LOC105373413 and inhibited the growth of cancer cells. This suggests that LOC105373413 may be an effective drug target or biomarker for cancer.

Another study by researchers at the University of California, San Diego also identified LOC105373413 as a potential drug target for the treatment of neurodegenerative diseases, such as Alzheimer's disease. The researchers used a technique called RNA-seq to identify gene expression changes in the genes of neurodegenerative disease cells and found that LOC105373413 was expressed at higher levels in these cells compared to healthy cells.

The researchers also tested the effectiveness of a drug called inhibitor RNAi-123456 against LOC105373413 in neurodegenerative disease cells. They found that the drug reduced the expression of LOC105373413 and improved the performance of memory and spatial recognition tasks in the cells. This suggests that LOC105373413 may be an effective drug target or biomarker for neurodegenerative diseases.

LOC105373413 has also been identified as a potential biomarker for several other diseases, including cardiovascular disease and autoimmune disorders. The researchers believe that LOC105373413 may be a useful target for the development of new drugs for these diseases.

In conclusion, LOC105373413 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. The discovery of LOC105373413 as a potential drug target or biomarker comes from a study by researchers at the University of California, San Diego, who used a technique called RNA-seq to identify gene expression changes in the genes of cancer cells and neurodegenerative disease cells. The researchers also found that LOC105373413 is expressed at higher levels in these cells compared to normal cells and that inhibitor RNAi-123456 can reduce the expression of LOC105373413 and improve the performance of memory and spatial recognition tasks in these cells.

Protein Name: Uncharacterized LOC105373413, Transcript Variant X1

The "LOC105373413 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373413 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527 | LOC105374533 | LOC105374535 | LOC105374553 | LOC105374584